Compsns. of thymopentin and interferon
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SINOPHARM A THINK PHARMA
- Publication Date
- 2006-09-20
Abstract
Description
Technical field:
[0001] The invention relates to a composition of thymopentin and interferon, which can be used for the treatment of viral diseases, especially for the treatment of viral hepatitis, especially hepatitis B, and can also be used for the adjuvant treatment of tumors . Background technique:
[0002] Interferon (IFN) is currently one of the two main drugs for the treatment of hepatitis B (the other is lamivudine), and its curative effect is definite. It mainly improves the immune response of the body through a series of endogenous biological reactions, promotes The body's clearance of exogenous viruses. According to the different producing cells and physiological functions, it is divided into families and subtypes such as IFNα, IFNβ, IFNγ, and IFNω.
[0003] Chronic hepatitis B virus (hereinafter referred to as HBV) is divided into three consecutive stages in immunopathology, that is, the immune tolerance period of high replication, the immune clearance period o...